Key points are not available for this paper at this time.
The FDA has approved a new radiopharmaceutical agent to assist in detecting causes of cognitive impairment other than Alzheimer's disease. But unique features of imaging information obtained with florbetapir F18 injection require careful consideration in diagnosis.
Building similarity graph...
Analyzing shared references across papers
Loading...
New England Journal of Medicine
Center for Drug Evaluation and Research
Add This Paper to Your Research Feed
Any time a new paper drops it will be there.
Yang et al. (Wed,) studied this question.